PHARMACEUTICAL PRESS REVIEW from 18 to 21 April of AboutPharma

Press Review from 18/04/08 to the 21/04/08 

"Bayer can race again"

(the Business Republic & Finance: p. 22 – 21 April 2008)

2008 didn't start well for Bayer, but Credit Suisse believes the German company has all the potential for a recovery. Analysts explain that 'in the first 3 months of the year, prices followed the decline of the German market. The cause must be sought in the negative developments in the healthcare sector and in the cyclical nature of the chemical sector'. For these reasons, the shares suffered a depreciation of approximately 20%. The German broker expects that a boost to the shares will come from an increase in profits, higher than estimates.

http://www.aboutpharma.it/notizia.asp?id=16455

The 1st quarter was positive for Novartis

(Les Echos online – April 21, 2008)

In the 1st quarter 2008, theNovartis net income increased 10% to $2.3 billion and revenue increased 8.6% to $9.9 billion.

http://www.aboutpharma.it/notizia.asp?id=16452

"Council of State. Chemotherapy also in clinics, a regional resolution suspended"